Abstract
Microsatellite markers may provide evidence of faulty DNA mismatch repair (MMR) via the detection of microsatellite instability (MSI). The choice of microsatellite markers may impact on the MSI detection rate. In hereditary non-polyposis colon cancer (HNPCC), several informative microsatellite markers have been recommended. Two of these, BAT 25 and BAT 26, are quasi-homozygous, enabling analysis of tumour DNA in the absence of paired normal DNA. Sixty-six breast cancer patients under 45 years of age at diagnosis were examined for MSI at BAT 25 and BAT 26. Tumour DNA was extracted from paraffin-embedded tissue. No MSI was detected at the BAT 25 or BAT 26 loci. An additional five microsatellite markers, known to be informative for HNPCC, were examined for MSI in these patients. Apparently-normal profiles were achieved. A tabulated survey of 306 microsatellite markers used to detect MSI in breast cancer revealed that only 35.5% of markers detected MSI at an average rate of 2.9%. The MSI detection rate at the specific HNPCC markers varied from 0% to 10% in breast cancer, with D175250 and TP53 being the HNPCC markers most suitable for analysis of breast cancer. The size of the microsatellite marker's repeat unit did not impact on MSI detection rates. Compiled data from large studies (n>100) revealed D115988 as the marker with the highest MSI detection rate. Genomic instability pathways of carcinogenesis, characterised by MMR defects and MSI, appear to play a role in the genesis of some breast cancer types.
Similar content being viewed by others
References
Rhyu MS: Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88: 240–251, 1996
Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87: 1114–1125, 1995
Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816, 1993
Arzimanoglou, II, Gilbert F, Barber HR: Microsatellite instability in human solid tumors. Cancer 82: 1808–1820, 1998
De Marchis L, Contegiacomo A, D'Amico C, Palmirotta R, Pizzi C, Ottini L, Mastranzo P, Figliolini M, Petrella G, Amanti C, Battista P, Bianco AR, Frati L, Cama A, Mariani-Costantini R: Microsatellite instability is correlated with lymph node-positive breast cancer. Clin Cancer Res 3: 241–248, 1997
Siah S-P, Quinn DM: Microsatellite markers in breast cancer. http://prmserv1/microsatellite-markers/, 1999
Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J: Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77: 1836–1843, 1996
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248–5257, 1998
Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R: BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57: 300–303, 1997
Zhou XP, Hoang JM, Li YJ, Seruca R, Carneiro F, Sobrinho-Simoes M, Lothe RA, Gleeson CM, Russell SE, Muzeau F, Flejou JF, Hoang-Xuan K, Lidereau R, Thomas G, Hamelin R: Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 21: 101–107, 1998
Zhou XP, Hoang JM, Cottu P, Thomas G, Hamelin R: Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene 15: 1713–1718, 1997
Samowitz WS, Slattery ML: Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes Chromosomes Cancer 26: 106–114, 1999
Provan AB, Hodges E, Smith AG, Smith JL: Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol 45: 763–765, 1992
Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55: 5548–5550, 1995
Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M: A second-generation linkage map of the human genome. Nature 359: 794–801, 1992
Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, King MC: Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50: 1235–1242, 1992
Weber JL, May PE: Dinucleotide repeat polymorphism at the D18S34 locus. Nucleic Acids Res 18: 3431, 1990
Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, David L, Holm R, Ryberg D, Haugen A, et al.: Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 53: 5853–5855, 1993
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994 Apr 8;77(1): 167]. Cell 75: 1027–1038, 1993
Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75: 1215–1225, 1993
Liu B, Farrington SM, Petersen GM, Hamilton SR, Parsons R, Papadopoulos N, Fujiwara T, Jen J, Kinzler KW, Wyllie AH, Vogelstein B, Dunlop MG: Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Medicine 1: 348–352, 1995
Walsh T, Chappell SA, Shaw JA, Walker RA: Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol 185: 18–24, 1998
Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S: Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9: 3695–3700, 1994
Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD, et al.: Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6: 152–156, 1994
Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53: 5087–5089, 1993
Bergthorsson JT, Egilsson V, Gudmundsson J, Arason A, Ingvarsson S: Identification of a breast tumor with micro satellite instability in a potential carrier of the hereditary non-polyposis colon cancer trait. Clin Genet 47: 305–310, 1995
Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, et al.: Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849–5852, 1993
Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, Toda T: Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features [In Process Citation]. Breast Cancer Res Treat 53: 33–39, 1999
Fujii S, Takeshima Y, Arihiro K, Kaneko M, Inai K: Microsatellite instability in breast cancers with special reference to patients' age and bilaterality. Hiroshima J Med Sci 47: 89–97, 1998
Sourvinos G, Kiaris H, Tsikkinis A, Vassilaros S, Spandidos DA: Microsatellite instability and loss of heterozygosity in primary breast tumours. Tumour Biol 18: 157–166, 1997
Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021–4026, 1996
Glebov OK, McKenzie KE, White CA, Sukumar S: Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 54: 3703–3709, 1994
Yee CJ, Roodi N, Verrier CS, Parl FF: Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 54: 1641–1644, 1994
Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, White S, Bird CC, Wyllie AH: Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene 12: 2641–2649, 1996
Shaw JA, Walsh T, Chappell SA, Carey N, Johnson K, Walker RA: Microsatellite instability in early sporadic breast cancer. Br J Cancer 73: 1393–1397, 1996
Contegiacomo A, Palmirotta R, De Marchis L, Pizzi C, Mastranzo P, Delrio P, Petrella G, Figliolini M, Bianco AR, Frati L, et al.: Microsatellite instability and pathological aspects of breast cancer. Int J Cancer 64: 264–268, 1995
Frazier ML, Sinicrope FA, Amos CI, Cleary KR, Lynch PM, Levin B, Luthra R: Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer. Oncol Rep 6: 497–505, 1999
Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89: 1758–1762, 1997
Jeffreys AJ, Royle NJ, Wilson V, Wong Z: Spontaneous mutation rates to new length alleles at tandem-repetitive hypervariable loci in human DNA. Nature 332: 278–281, 1988
Jonsson M, Johannsson O, Borg A: Infrequent occurrence of microsatellite instability in sporadic and familial breast cancer. Eur J Cancer 31A: 2330–2334, 1995
Hu RJ, Lee MP, Connors TD, Johnson LA, Burn TC, Su K, Landes GM, Feinberg AP: A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics 46: 9–17, 1997
Hoggard N, Brintnell B, Howell A, Weissenbach J, Varley J: Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes Chromosomes Cancer 12: 24–31, 1995
Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075–3079, 1991
Loeb LA: Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059–5063, 1994
Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159–170, 1996
Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B: Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300–303, 1998
Orr-Weaver TL, Weinberg RA: A checkpoint on the road to cancer [news; cornment]. Nature 392: 223–224, 1998
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP: CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681–8686, 1999
Deng G, Chen A, Hong J, Chae HS, Kim YS: Methylation of CpG in a small region of the hMLH 1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029–2033, 1999
Williams C, Norberg T, Ahmadian A, Ponten F, Bergh J, Inganas M, Lundeberg J, Uhlen M: Assessment of sequencebased p53 gene analysis in human breast cancer: messenger RNA in comparison with genomic DNA targets. Clin Chem 44: 455–462, 1998
Bergthorsson JT, Eiriksdottir G, Barkardottir RB, Egilsson V, Arason A, Ingvarsson S: Linkage analysis and allelic imbalance in human breast cancer kindreds using microsatellite markers from the short arm of chromosome 3. Hum Genet 96: 437–443, 1995
Benachenhou N, Guiral S, Gorska-Flipot I, Labuda D, Sinnett D: Frequent loss of heterozygosity at the DNA mismatchrepair loci hMLHI and hMSH3 in sporadic breast cancer. Br J Cancer 79: 1012–1017, 1999
Schmitt FC, Soares R, Gobbi H, Milanezzi F, Santos-Silva F, Cirnes L, Costa C, Seruca R: Microsatellite instability in medullary breast carcinomas. Int J Cancer 82: 644–647, 1999
Karnik P, Plummer S, Casey G, Myles J, Tubbs R, Crowe J, Williams BR: Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis. Hum Mol Genet 4: 1889–1894, 1995
Vaurs-Barriere C, Vidal V, Penault-Llorca F, Kwiatkowski F, Maugard C, Bignon Y: Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability. Int J Oncol 12: 1373–1378, 1998
Krajinovic M, Richer C, Gorska-Flipot I, Gaboury L, Novakovic I, Labuda D, Sinnett D: Genomic loci susceptible to replication errors in cancer cells. Br J Cancer 78: 981–985, 1998
Chappell SA, Walsh T, Walker RA, Shaw JA: Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 75: 1324–1329, 1997
Cropp CS, Champeme MH, Lidereau R, Callahan R: Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53: 5617–5619, 1993
Dillon EK, de Boer WB, Papadimitriou JM, Turbett GR: Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Cancer 76: 156–162, 1997
McCulloch RK, Sellner LN, Papadimitrou JM, Turbett GR: The incidence of microsatellite instability and loss of heterozygosity in fibroadenoma of the breast. Breast Cancer Res Treat 49: 165–169, 1998
Laake K, Odegard A, Andersen TI, Bukholm IK, Karesen R, Nesland JM, Ottestad L, Shiloh Y, Borresen-Dale AL: Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18: 175–180, 1997
Chen T, Sahin A, Aldaz CM: Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res 56: 5605–5609, 1996
Vincent F, Hagiwara K, Ke Y, Stoner GD, Demetrick DJ, Bennett WP: Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast. Biochem Biophys Res Commun 223: 561–564, 1996
Koreth J, Bakkenist CJ, McGee JO: Allelic deletions at chromosome 11q22–q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Oncogene 14: 431–437, 1997
Tomlinson IP, Nicolai H, Solomon E, Bodmer WF: The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J Pathol 180: 38–43, 1996
Futreal PA, Soderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW: Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52: 2624–2627, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siah, S.P., Siah, S.P., Quinn, D.M. et al. Microsatellite instability markers in breast cancer: A review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 60, 135–142 (2000). https://doi.org/10.1023/A:1006315315060
Issue Date:
DOI: https://doi.org/10.1023/A:1006315315060